NCT05172479

Brief Summary

Early identification of a patient with infection who may develop sepsis is of utmost importance. Unfortunately, this remains elusive because no single clinical measure or test can reflect complex pathophysiological changes in patients with sepsis. However, multiple clinical and laboratory parameters indicate impending sepsis and organ dysfunction. Screening tools using these parameters can help identify the condition, such as SIRS, quick SOFA (qSOFA), National Early Warning Score (NEWS), or Modified Early Warning Score (MEWS). The 2016 SCCM/ESICM task force recommended using qSOFA, while the 2021 Surviving Sepsis Campaign strongly recommended against its use compared with SIRS, NEWS, or MEWS as a single screening tool for sepsis or septic shock. We hypothesised that qSOFA has greater prognostic accuracy than SIRS and EWS (NEWS/NEWS2/MEWS).

Trial Health

93
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
3,274

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Dec 2021

Geographic Reach
7 countries

20 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 3, 2021

Completed
9 days until next milestone

Study Start

First participant enrolled

December 12, 2021

Completed
17 days until next milestone

First Posted

Study publicly available on registry

December 29, 2021

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 11, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 11, 2023

Completed
Last Updated

September 13, 2023

Status Verified

September 1, 2023

Enrollment Period

1.7 years

First QC Date

December 3, 2021

Last Update Submit

September 10, 2023

Conditions

Keywords

SepsisSeptic shockqSOFASIRSEWSNEWSNEWS2MEWSEmergency department

Outcome Measures

Primary Outcomes (1)

  • In-hospital mortality

    Mortality rate during hospitalization of patient

    30 days

Secondary Outcomes (2)

  • Intensive care unit admission

    30 days

  • Length of stay in the intensive care unit

    30 days

Study Arms (10)

Positive qSOFA

Adult patients with suspected infection and a qSOFA score ≥ 2 at the triage in the ED who are planned for hospitalization

Diagnostic Test: Measurement of qSOFA score

Negative qSOFA

Adult patients with suspected infection and a qSOFA score \< 2 at the triage in the ED who are planned for hospitalization

Diagnostic Test: Measurement of qSOFA score

Positive SIRS

Adult patients with suspected infection and a SIRS criteria ≥ 2 at the triage in the ED who are planned for hospitalization

Diagnostic Test: Measurement of SIRS criteria

Negative SIRS

Adult patients with suspected infection and a SIRS criteria \< 2 at the triage in the ED who are planned for hospitalization

Diagnostic Test: Measurement of SIRS criteria

Positive NEWS

Adult patients with suspected infection and a NEWS ≥ 5 or red score (i.e., a score of 3 in any one parameter) at the triage in the ED who are planned for hospitalization

Diagnostic Test: Measurement of NEWS

Negative NEWS

Adult patients with suspected infection and a NEWS \< 5 at the triage in the ED who are planned for hospitalization

Diagnostic Test: Measurement of NEWS

Positive NEWS2

Adult patients with suspected infection and a NEWS2 ≥ 5 or red score (i.e., a score of 3 in any one parameter) at the triage in the ED who are planned for hospitalization

Diagnostic Test: Measurement of NEWS2

Negative NEWS2

Adult patients with suspected infection and a NEWS2 \< 5 at the triage in the ED who are planned for hospitalization

Diagnostic Test: Measurement of NEWS2

Positive MEWS

Adult patients with suspected infection and a MEWS ≥ 5 at the triage in the ED who are planned for hospitalization

Diagnostic Test: Measurement of MEWS

Negative MEWS

Adult patients with suspected infection and a MEWS \< 5 at the triage in the ED who are planned for hospitalization

Diagnostic Test: Measurement of MEWS

Interventions

At the patient's arrival to the ED triage, the nurse will enter the patient's vital signs data into electronic data capture (EDC) system that will calculate the patient's qSOFA score.

Also known as: quick Sequential Organ Failure Assessment (qSOFA)
Negative qSOFAPositive qSOFA

At the patient's arrival to the ED triage, the nurse will enter the patient's vital signs data into electronic data capture (EDC) system that will calculate the patient's SIRS criteria.

Also known as: Systemic inflammatory response syndrome (SIRS)
Negative SIRSPositive SIRS
Measurement of NEWSDIAGNOSTIC_TEST

At the patient's arrival to the ED triage, the nurse will enter the patient's vital signs data into electronic data capture (EDC) system that will calculate the patient's NEWS.

Also known as: National Early Warning Score (NEWS)
Negative NEWSPositive NEWS
Measurement of NEWS2DIAGNOSTIC_TEST

At the patient's arrival to the ED triage, the nurse will enter the patient's vital signs data into electronic data capture (EDC) system that will calculate the patient's NEWS2.

Also known as: National Early Warning Score 2 (NEWS2)
Negative NEWS2Positive NEWS2
Measurement of MEWSDIAGNOSTIC_TEST

At the patient's arrival to the ED triage, the nurse will enter the patient's vital signs data into electronic data capture (EDC) system that will calculate the patient's MEWS.

Also known as: Modified Early Warning Score (MEWS)
Negative MEWSPositive MEWS

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

All consecutive adult patients (age ≥18 years) presenting to the ED with suspected infection who planned to be hospitalized and willing to give informed consent (if required by recruiting center IRB) are eligible. A presumptive diagnosis of infection will be judged based on the opinion of the emergency physician upon the initial patient presentation to the ED. We will exclude patients with evidence of other causes of presentation to the ED other than infection (e.g., autoimmune diseases, myocardial infarction, trauma, …etc.), pregnant ladies, those who transferred from other hospitals, those not planned for hospitalization, or those who admitted electively to the hospital through ED. We will also exclude patients whose initial diagnosis of infection in the ED was not confirmed after the recruitment and follow-up.

You may qualify if:

  • Adult patients (age ≥18 years),
  • Suspected infection (based on the opinion of the emergency physician),
  • Planned for hospitalization,
  • Willing to give oral informed consent (if required by recruiting center's IRB).

You may not qualify if:

  • Presentation to ED is not due to infection (e.g., autoimmune diseases, myocardial infarction, stroke, venous thromboembolism, trauma, intoxication … etc.),
  • Pregnancy,
  • Transferred from another hospitals,
  • Code status is "Do-Not-Resuscitate" (DNR)
  • Elective admission through ED
  • Initial diagnosis of infection in the ED was not confirmed after finishing of the recruitment and follow-up phase.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (20)

Bahrain Defence Force Hospital

Riffa, Southern Governorate, 947, Bahrain

Location

King Hamad University Hospital

Al Muharraq, Bahrain

Location

Amiri Hospital

Kuwait City, Kuwait

Location

Armed Forces Hospital Oman

Muscat, 111, Oman

Location

Hamad Medical Corporation

Doha, Qatar

Location

Aseer Central Hospital (ACH)

Abhā, Aseer Province, 62523, Saudi Arabia

Location

Armed Force Hospital Southern Region-Khamis Mushayt (AFHSR-KM)

Khamis Mushait, Aseer Province, 62413, Saudi Arabia

Location

King Fahad Specialist Hospital

Dammam, Eastern Province, 32253, Saudi Arabia

Location

Johns Hopkins Aramco Healthcare

Dhahran, Eastern Province, 34465, Saudi Arabia

Location

Royal Commission Hospital in Jubail

Jubail, Eastern Province, 31961, Saudi Arabia

Location

King Abdulaziz University Hospital

Jeddah, Makkah Al Mukarramah Province, 22252, Saudi Arabia

Location

King Fahd Armed Forces Hospital

Jeddah, Makkah Al Mukarramah Province, 23311, Saudi Arabia

Location

North Medical Tower

Arar, Northern Borders Province, 73241, Saudi Arabia

Location

King Abdullah bin Abdulaziz University Hospital (KAAUH)

Riyadh, Riyadh Region, 11564, Saudi Arabia

Location

King Fahad Medical City (KFMC)

Riyadh, Riyadh Region, 12231, Saudi Arabia

Location

King Saud Medical City (KSMC)

Riyadh, Riyadh Region, 12746, Saudi Arabia

Location

Sulaiman Al-Habib Hospital

Riyadh, Saudi Arabia

Location

Kocaeli University Hospital

Kocaeli, 41380, Turkey (Türkiye)

Location

Sheikh Shakhbout Medical City

Abu Dhabi, United Arab Emirates

Location

Rashid Hospital

Dubai, United Arab Emirates

Location

Related Publications (1)

  • Algarni AM, Alfaifi MS, Al Bshabshe AA, Omair OM, Alsultan MA, Alzahrani HM, Alali HE, Alsabaani AA, Alqarni AM, Alghanem SA, Al Mufareh BS, Almemari AM, Sindi AA, Ozturan IU, Alhadhira AA, Shujaa AS, Alotaibi AH, Awladthani MM, Alsaad AA, Almarshed AA, AlQahtani AM, Harris TR, Alyahya BA, Assiri SA, Abuzeyad FH, Kazim SN, Al-Fares AA, Almazroua FY, Marzook NT, Basri AA, Elsafti AM, Alalshaikh AS, Ozturan CA, Alawad YI, AlOmari A, Alkhateeb MA, Farooq MM, AlMutairi LA, Alasfour MM, Al Haber MI, Umar UA, Bokhary NH, Alqahtani SF, Almutairi A, Alyahya HF, Alzahrani WS, Alsalmi F, Omair AM, Alasmari FM, Alfifi SY, Al-Nujimi MS, Foroutan F. Prognostic accuracy of qSOFA score, SIRS criteria, and EWSs for in-hospital mortality among adult patients presenting with suspected infection to the emergency department (PASSEM) Multicenter prospective external validation cohort study protocol. PLoS One. 2024 Jan 17;19(1):e0281208. doi: 10.1371/journal.pone.0281208. eCollection 2024.

    PMID: 38232095BACKGROUND

Related Links

MeSH Terms

Conditions

SepsisShock, SepticEmergencies

Condition Hierarchy (Ancestors)

InfectionsSystemic Inflammatory Response SyndromeInflammationPathologic ProcessesPathological Conditions, Signs and SymptomsShockDisease Attributes

Study Officials

  • Abdullah M Algarni, MBBS

    Aseer Central Hospital (ACH)

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Family medicine consultant

Study Record Dates

First Submitted

December 3, 2021

First Posted

December 29, 2021

Study Start

December 12, 2021

Primary Completion

September 11, 2023

Study Completion

September 11, 2023

Last Updated

September 13, 2023

Record last verified: 2023-09

Locations